122 related articles for article (PubMed ID: 23421371)
21. Human CD56bright and CD56dim natural killer cell subsets respond differentially to direct stimulation with Mycobacterium bovis bacillus Calmette-Guérin.
Batoni G; Esin S; Favilli F; Pardini M; Bottai D; Maisetta G; Florio W; Campa M
Scand J Immunol; 2005 Dec; 62(6):498-506. PubMed ID: 16316416
[TBL] [Abstract][Full Text] [Related]
22. IL-7 enhances survival of human CD56bright NK cells.
Michaud A; Dardari R; Charrier E; Cordeiro P; Herblot S; Duval M
J Immunother; 2010 May; 33(4):382-90. PubMed ID: 20386468
[TBL] [Abstract][Full Text] [Related]
23. Hcmv-miR-UL112 attenuates NK cell activity by inhibition type I interferon secretion.
Huang Y; Chen D; He J; Cai J; Shen K; Liu X; Yang X; Xu L
Immunol Lett; 2015 Feb; 163(2):151-6. PubMed ID: 25530545
[TBL] [Abstract][Full Text] [Related]
24. Novel aspects of in vitro IL-2 or IFN-α enhanced NK cytotoxicity of healthy individuals based on NKG2D and CD161 NK cell receptor induction.
Konjević G; Mirjačić Martinović K; Vuletić A; Radenković S
Biomed Pharmacother; 2010 Dec; 64(10):663-71. PubMed ID: 20800424
[TBL] [Abstract][Full Text] [Related]
25. Induction of CD16+ CD56bright NK cells with antitumour cytotoxicity not only from CD16- CD56bright NK Cells but also from CD16- CD56dim NK cells.
Takahashi E; Kuranaga N; Satoh K; Habu Y; Shinomiya N; Asano T; Seki S; Hayakawa M
Scand J Immunol; 2007 Feb; 65(2):126-38. PubMed ID: 17257217
[TBL] [Abstract][Full Text] [Related]
26. Effect of influenza A infection on umbilical cord blood natural killer function regulation with interleukin-15.
Lin SJ; Cheng PJ; Lin TY; Lee PT; Hsiao HS; Kuo ML
J Infect Dis; 2012 Mar; 205(5):745-56. PubMed ID: 22262794
[TBL] [Abstract][Full Text] [Related]
27. Activation of NK Cells in Mixed Cultures of Wharton's Jelly Mesenchymal Stromal Cells and Peripheral Blood Lymphocytes.
Svirshchevskaya EV; Poltavtsev AM; Os'mak GZ; Poltavtseva RA
Bull Exp Biol Med; 2018 Jan; 164(3):339-343. PubMed ID: 29313232
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of natural, interleukin-2 stimulated and bacillus Calmette-Guerin enhanced cytotoxicity with anti-CD16 antibodies.
Kaasinen ES; Harju LM; Timonen TT
J Urol; 2002 May; 167(5):2209-14. PubMed ID: 11956480
[TBL] [Abstract][Full Text] [Related]
29. Distinct phenotypic and functional characteristics of human natural killer cells obtained by rapid interleukin 2-induced adherence to plastic.
Vujanovic NL; Rabinowich H; Lee YJ; Jost L; Herberman RB; Whiteside TL
Cell Immunol; 1993 Oct; 151(1):133-57. PubMed ID: 8402925
[TBL] [Abstract][Full Text] [Related]
30. Increased frequency of ILT2-expressing CD56(dim)CD16(+) NK cells correlates with disease severity of pulmonary tuberculosis.
Wang X; Meng X; Zheng Y; Jiang J; Yang B; Liu Y; Zhai F; Cheng X
Tuberculosis (Edinb); 2014 Sep; 94(5):469-74. PubMed ID: 24909369
[TBL] [Abstract][Full Text] [Related]
31. Interleukin-18 (IL-18) synergizes with IL-2 to enhance cytotoxicity, interferon-gamma production, and expansion of natural killer cells.
Son YI; Dallal RM; Mailliard RB; Egawa S; Jonak ZL; Lotze MT
Cancer Res; 2001 Feb; 61(3):884-8. PubMed ID: 11221875
[TBL] [Abstract][Full Text] [Related]
32. Natural killer cell mediated cytotoxicity of tumor cells initiated by neem leaf preparation is associated with CD40-CD40L-mediated endogenous production of interleukin-12.
Bose A; Baral R
Hum Immunol; 2007 Oct; 68(10):823-31. PubMed ID: 17961770
[TBL] [Abstract][Full Text] [Related]
33. Effect of interleukin-15 and Flt3-ligand on natural killer cell expansion and activation: umbilical cord vs. adult peripheral blood mononuclear cells.
Lin SJ; Yang MH; Chao HC; Kuo ML; Huang JL
Pediatr Allergy Immunol; 2000 Aug; 11(3):168-74. PubMed ID: 10981526
[TBL] [Abstract][Full Text] [Related]
34. Role of CD16 (Fc receptor III) and interleukin-2 in the reactivation of natural killer cells after inhibitory target cell contact.
Heiskala M; Ståhls A; Seppälä I; Timonen T
Nat Immun Cell Growth Regul; 1991; 10(5):265-77. PubMed ID: 1836835
[TBL] [Abstract][Full Text] [Related]
35. Changes in gene expression associated with IFN-beta and IL-2-induced augmentation of human natural killer cell function.
Kornbluth J; Hoover RG
J Immunol; 1988 Nov; 141(9):3234-40. PubMed ID: 3049820
[TBL] [Abstract][Full Text] [Related]
36. Natural killer cell immunodeficiency in HIV disease is manifest by profoundly decreased numbers of CD16+CD56+ cells and expansion of a population of CD16dimCD56- cells with low lytic activity.
Hu PF; Hultin LE; Hultin P; Hausner MA; Hirji K; Jewett A; Bonavida B; Detels R; Giorgi JV
J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Nov; 10(3):331-40. PubMed ID: 7552495
[TBL] [Abstract][Full Text] [Related]
37. Phase I evaluation of combination therapy with interleukin 2 and gamma-interferon.
Weiner LM; Padavic-Shaller K; Kitson J; Watts P; Krigel RL; Litwin S
Cancer Res; 1991 Aug; 51(15):3910-8. PubMed ID: 1906779
[TBL] [Abstract][Full Text] [Related]
38. Combined effects of immunity and antitumor drugs against cancer. II. In vitro studies with cis-diamminedichloroplatinum in a human leukemia system.
De Filippi R; Fuggetta MP; Ricci F; Marini S; Caliendo R; Giuliani A
Chemioterapia; 1987 Dec; 6(6):410-6. PubMed ID: 2449291
[TBL] [Abstract][Full Text] [Related]
39. The role of IL-4 in proliferation and differentiation of human natural killer cells. Study of an IL-4-dependent versus an IL-2-dependent natural killer cell clone.
Hayakawa K; Salmeron MA; Kornbluth J; Bucana C; Itoh K
J Immunol; 1991 Apr; 146(7):2453-60. PubMed ID: 1900882
[TBL] [Abstract][Full Text] [Related]
40. Lymphokine-activated killer activity in long-term cultures with anti-CD3 plus interleukin 2: identification and isolation of effector subsets.
Ochoa AC; Hasz DE; Rezonzew R; Anderson PM; Bach FH
Cancer Res; 1989 Feb; 49(4):963-8. PubMed ID: 2521457
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
